# US 2013/0160166 A1 · Oral insulin therapy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0160166 A1
- Document ID: US20130160166A1
- Status: Published application
- Kind: A1
- Application number: 13/679,586
- Filed: 2012-11-16
- Published: 2013-06-20
- Earliest claimed: 2011-11-18
- Assignees: University of Central Florida Research Foundation, Inc.
- Inventors: Henry Daniell
- Web page: https://patentgrep.com/patent/US20130160166A1

## CPC

- C07K 14/575: Hormones (derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin C07K14/665, e.g. corticotropin C07K14/695)
- C07K 14/195: from bacteria
- C07K 14/62: Insulins
- C12N 15/8214: {Plastid transformation}
- C12N 15/8257: {for the production of primary gene products, e.g. pharmaceutical products, interferon}
- C07K 2319/50: containing protease site
- C07K 2319/55: containing a fusion with a toxin, e.g. diphteria toxin
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

This disclosure relates in part to synthesizing a cleavable proinsulin construct in transgenic plants by chloroplast expression.

## Claims

### Claim 1

A cleavable proinsulin construct comprising:
a cholera toxin B (CTB) subunit fused to a proinsulin subunit; and
at least one furin cleavage site on the cleavable proinsulin construct.

### Claim 2 (depends on 1)

The cleavable proinsulin construct of claim 1, wherein the proinsulin subunit comprises a C peptide

### Claim 3 (depends on 2)

The cleavable proinsulin construct of claim 2, wherein the proinsulin subunit further comprises an A chain and a B chain, and wherein the C peptide is disposed between the A chain and the B chain.

### Claim 4 (depends on 2)

The cleavable proinsulin construct of claim 2, wherein the at least one furin cleavage site comprises a pair of furin cleavage sites flanking each side of the C-peptide.

### Claim 5 (depends on 1)

The cleavable proinsulin construct of claim 1, wherein the at least one furin cleavage site comprises a furin cleavage site located at a junction between the CTB subunit and the proinsulin subunit.

### Claim 6 (depends on 5)

The cleavable proinsulin construct of claim 5, further comprising a GPGP (SEQ ID NO: 2) hinge sequence between the CTB sequence and the furin cleavage site.

### Claim 7 (depends on 1)

The cleavable proinsulin construct of claim 1, wherein the at least one furin cleavage site comprises three furin cleavage sites.

### Claim 8 (depends on 1)

The cleavable proinsulin construct of claim 1, wherein the proinsulin subunit comprises a C peptide, an A chain, and a B chain, and wherein the C peptide is disposed between the A chain and the B chain, wherein the at least one furin cleavage site comprises three furin cleavage sites, wherein first and second furin cleavage sites flank opposed sides of the C-peptide, and wherein a third furin cleavage site is located at a junction between the CTB subunit and the proinsulin subunit.

### Claim 9 (depends on 1)

The cleavable proinsulin construct of claim 1, wherein the at least one furin cleavage site comprises an Arg Arg Lys Arg (SEQ ID NO: 3) furin cleavage sequence.

### Claim 10 (depends on 1)

The cleavable proinsulin construct of claim 1, wherein the cleavable insulin construct is CTB-PFx3.

### Claim 11 (depends on 1)

A DNA construct that encodes, upon expression in a plant cell, the cleavable proinsulin construct of claim 1.

### Claim 12 (depends on 11)

The DNA construct of claim 11, wherein the proinsulin subunit comprises a C peptide.

### Claim 13 (depends on 12)

The cleavable proinsulin construct of claim 12, wherein the proinsulin subunit further comprises an A chain and a B chain, and wherein the C peptide is disposed between the A chain and the B chain.

### Claim 14 (depends on 12)

The cleavable proinsulin construct of claim 12, wherein the at least one furin cleavage comprises a cleavage site that flanks the C-peptide.

### Claim 15 (depends on 11)

The cleavable proinsulin construct of claim 11, wherein the proinsulin subunit comprises a C peptide, an A chain, and a B chain, and wherein the C peptide is disposed between the A chain and the B chain, wherein the at least one furin cleavage site comprises three furin cleavage sites, wherein first and second furin cleavage sites flank opposed sides of the C-peptide, and wherein a third furin cleavage site is located at a junction between the CTB subunit and the proinsulin subunit.

### Claim 16 (depends on 11)

A transgenic plant transformed with the DNA construct of claim 11.

### Claim 17 (depends on 16)

The transgenic plant of claim 16, wherein the transgenic plant is selected from the group consisting of a tobacco and a lettuce plant.

### Claim 18 (depends on 15)

A transgenic plant transformed with the DNA construct of claim 15.

### Claim 19 (depends on 16)

The transgenic plant of claim 16, wherein the transgenic plant is selected from the group consisting of a tobacco and a lettuce plant.

### Claim 20 (depends on 1)

A plant cell, wherein said plant cell comprises chloroplasts transformed to express the cleavable proinsulin construct of claim 1.

### Claim at position 21

21-45. (canceled)
